R
Revenio Group Oyj
OTC:REVXF
Revenio Group Oyj
OTC:REVXF
Price:
25
USD
Market Closed
Market Cap:
$664.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Revenio Group Oyj
OTC:REVXF
|
FI |
|
Kokuyo Co Ltd
TSE:7984
|
JP |
|
Gimv NV
XBRU:GIMB
|
BE |
|
V
|
Vitesse Energy Inc
NYSE:VTS
|
US |
|
O
|
Oldfields Holdings Ltd
ASX:OLH
|
AU |
|
Boa Vista Servicos SA
BOVESPA:BOAS3
|
BR |
|
A
|
Al Jouf Cement Company SJSC
SAU:3091
|
SA |
|
Xuelong Group Co Ltd
SSE:603949
|
CN |
|
O
|
Orkla ASA
SWB:OKL
|
NO |
|
V
|
Va Tech Wabag Ltd
NSE:WABAG
|
IN |
|
Musashi Seimitsu Industry Co Ltd
TSE:7220
|
JP |
|
T
|
Teleste Oyj
F:TS6
|
FI |
|
DFM Foods Ltd
NSE:DFMFOODS
|
IN |
|
B
|
BYGGFAKTA GROUP Nordic HoldCo AB
LSE:0AAC
|
SE |
|
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
CN |
|
M
|
Magnum Ice Cream Company NV
AEX:MICC
|
NL |
Multiples-Based Value
The Multiples-Based Value of one REVXF stock under the Base Case scenario is hidden USD. Compared to the current market price of 25 USD, Revenio Group Oyj is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REVXF Multiples-Based Value
LOCKED
Multiples Across Competitors
REVXF Competitors Multiples
Revenio Group Oyj Competitors
Revenio Group Oyj Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
R
|
Revenio Group Oyj
OTC:REVXF
|
479.9m USD | 4.3 | 26.8 | 14.9 | 17.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
176.4B USD | 4 | 27 | 15.5 | 21.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.3B USD | 16.5 | 58.2 | 44.1 | 54.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
130.5B USD | 5.2 | 40.2 | 20.5 | 24.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.8B USD | 3.2 | 24.2 | 13.4 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.8B USD | 4.8 | 33.1 | 19.6 | 26.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.2B EUR | 1.9 | 20.5 | 11.4 | 16.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.3B USD | 10.8 | 43.7 | 31 | 34.3 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.5 | 42.3 | 23 | 25.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.5B USD | 1.6 | 16.1 | 11.5 | 14 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
